These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 30208915)

  • 1. A continuous repetitive task to detect fatigability in spinal muscular atrophy.
    Stam M; Wadman RI; Bartels B; Leeuw M; Westeneng HJ; Wijngaarde CA; van den Berg LH; van der Pol WL
    Orphanet J Rare Dis; 2018 Sep; 13(1):160. PubMed ID: 30208915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatigability in spinal muscular atrophy: validity and reliability of endurance shuttle tests.
    Bartels B; de Groot JF; Habets LE; Wijngaarde CA; Vink W; Stam M; Asselman FL; van Eijk RPA; van der Pol WL
    Orphanet J Rare Dis; 2020 Mar; 15(1):75. PubMed ID: 32293503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceived Fatigue in Spinal Muscular Atrophy: A Pilot Study.
    Dunaway Young S; Montes J; Kramer SS; Podwika B; Rao AK; De Vivo DC
    J Neuromuscul Dis; 2019; 6(1):109-117. PubMed ID: 30562906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial).
    Stam M; Wadman RI; Wijngaarde CA; Bartels B; Asselman FL; Otto LAM; Goedee HS; Habets LE; de Groot JF; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    BMJ Open; 2018 Jul; 8(7):e019932. PubMed ID: 30061431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of Fatigability in Patients With Spinal Muscular Atrophy.
    Bartels B; de Groot JF; Habets LE; Wadman RI; Asselman FL; Nieuwenhuis EES; van Eijk RPA; Goedee HS; van der Pol WL
    Neurology; 2021 Feb; 96(6):e845-e852. PubMed ID: 33219141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6MWT can identify type 3 SMA patients with neuromuscular junction dysfunction.
    Pera MC; Luigetti M; Pane M; Coratti G; Forcina N; Fanelli L; Mazzone ES; Antonaci L; Lapenta L; Palermo C; Ranalli D; Granata G; Lomonaco M; Servidei S; Mercuri E
    Neuromuscul Disord; 2017 Oct; 27(10):879-882. PubMed ID: 28803817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of fatigability in patients with spinal muscular atrophy: development and content validity of a set of endurance tests.
    Bartels B; Habets LE; Stam M; Wadman RI; Wijngaarde CA; Schoenmakers MAGC; Takken T; Hulzebos EHJ; van der Pol WL; de Groot JF
    BMC Neurol; 2019 Feb; 19(1):21. PubMed ID: 30738436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunction of the neuromuscular junction in spinal muscular atrophy types 2 and 3.
    Wadman RI; Vrancken AF; van den Berg LH; van der Pol WL
    Neurology; 2012 Nov; 79(20):2050-5. PubMed ID: 23115209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responsiveness of the motor function measure in patients with spinal muscular atrophy.
    Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C;
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac function evaluation in children with spinal muscular atrophy: A case-control study.
    He X; Li X; Yan M; Peng H; Zhang L; Liang Y; Tang W; Li S
    Pediatr Int; 2024; 66(1):e15769. PubMed ID: 38742693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of spinal muscular atrophy (SMA) type 3 (Kugelberg-Welander disease).
    Salort-Campana E; Quijano-Roy S
    Arch Pediatr; 2020 Dec; 27(7S):7S23-7S28. PubMed ID: 33357593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bulbar muscle MRI changes in patients with SMA with reduced mouth opening and dysphagia.
    Wadman RI; van Bruggen HW; Witkamp TD; Sparreboom-Kalaykova SI; Stam M; van den Berg LH; Steenks MH; van der Pol WL
    Neurology; 2014 Sep; 83(12):1060-6. PubMed ID: 25122201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatigue leads to gait changes in spinal muscular atrophy.
    Montes J; Dunaway S; Montgomery MJ; Sproule D; Kaufmann P; De Vivo DC; Rao AK
    Muscle Nerve; 2011 Apr; 43(4):485-8. PubMed ID: 21404286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy Controls.
    Wadman RI; Stam M; Jansen MD; van der Weegen Y; Wijngaarde CA; Harschnitz O; Sodaar P; Braun KP; Dooijes D; Lemmink HH; van den Berg LH; van der Pol WL
    PLoS One; 2016; 11(11):e0167087. PubMed ID: 27893852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersen.
    Govoni A; Ricci G; Bonanno S; Bello L; Magri F; Meneri M; Torri F; Caponnetto C; Passamano L; Grandis M; Trojsi F; Cerri F; Gadaleta G; Capece G; Caumo L; Tanel R; Saccani E; Vacchiano V; Sorarù G; D'Errico E; Tramacere I; Bortolani S; Rolle E; Gellera C; Zanin R; Silvestrini M; Politano L; Schenone A; Previtali SC; Berardinelli A; Turri M; Verriello L; Coccia M; Mantegazza R; Liguori R; Filosto M; Maioli MA; Simone IL; Mongini T; Corti S; Manca ML; Pegoraro E; Siciliano G; Comi GP; Maggi L
    Muscle Nerve; 2024 Oct; 70(4):816-823. PubMed ID: 39096012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical considerations in the study of spinal muscular atrophy. Dallas-Cincinnati-Newington Spinal Muscular Atrophy (DCN-SMA) Study Group.
    Buncher CR; Samaha F; Iannaccone ST; Russman BS; Cook JD; White M; McLaughlin C
    Muscle Nerve; 1990; 13 Suppl():S45-8. PubMed ID: 2233886
    [No Abstract]   [Full Text] [Related]  

  • 17. Prominent fatigue in spinal muscular atrophy and spinal and bulbar muscular atrophy: evidence of activity-dependent conduction block.
    Noto Y; Misawa S; Mori M; Kawaguchi N; Kanai K; Shibuya K; Isose S; Nasu S; Sekiguchi Y; Beppu M; Ohmori S; Nakagawa M; Kuwabara S
    Clin Neurophysiol; 2013 Sep; 124(9):1893-8. PubMed ID: 23643309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international study.
    Coratti G; Bovis F; Pera MC; Scoto M; Montes J; Pasternak A; Mayhew A; Muni-Lofra R; Duong T; Rohwer A; Dunaway Young S; Civitello M; Salmin F; Mizzoni I; Morando S; Pane M; Albamonte E; D'Amico A; Brolatti N; Sframeli M; Marini-Bettolo C; Sansone VA; Bruno C; Messina S; Bertini E; Baranello G; Day J; Darras BT; De Vivo DC; Hirano M; Muntoni F; Finkel R; Mercuri E;
    Eur J Neurol; 2024 Aug; 31(8):e16309. PubMed ID: 38656662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability, validity and responsiveness of inertial measurement units for assessing motor recovery after gene therapy in infants with early onset spinal muscular atrophy: a prospective cohort study.
    Barrois R; Tervil B; Cacioppo M; Barnerias C; Deladrière E; Leloup-Germa V; Hervé A; Oudre L; Ricard D; Vidal PP; Vayatis N; Roy SQ; Brochard S; Gitiaux C; Desguerre I
    J Neuroeng Rehabil; 2024 Oct; 21(1):183. PubMed ID: 39415296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.
    Wadman RI; Wijngaarde CA; Stam M; Bartels B; Otto LAM; Lemmink HH; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    Eur J Neurol; 2018 Mar; 25(3):512-518. PubMed ID: 29194869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.